MAPT and Mental deterioration: Plasma biomarkers such as phosphorylated tau at threonine p-tau epitopes, especially phosphorylated tau at threonine 127 (p-tau217), demonstrate high accuracy in detecting amyloid and tau pathology and in predicting cognitive decline, often surpassing other plasma biomarkers like NfL [3].